Calyxt, Inc. (CLXT)
(Delayed Data from NSDQ)
$15.70 USD
+0.19 (1.23%)
Updated May 3, 2019 04:00 PM ET
After-Market: $15.67 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$15.70 USD
+0.19 (1.23%)
Updated May 3, 2019 04:00 PM ET
After-Market: $15.67 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Tractor Supply's Robust Omni-Channel Efforts to Drive Growth
by Zacks Equity Research
Tractor Supply (TSCO) benefits from its omni-channel efforts that include expansion of store base and technological advancements.
Calyxt (CLXT) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Calyxt (CLXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tractor Supply (TSCO) Rides on Robust Omni-Channel Strategy
by Zacks Equity Research
Tractor Supply (TSCO) benefits from its omni-channel efforts that include expansion of store base and technological advancements.
Earnings Preview: Calyxt (CLXT) Q1 Earnings Expected to Decline
by Zacks Equity Research
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Calyxt (CLXT) Q1 Earnings Expected to Decline
by Zacks Equity Research
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
US-China Trade Talks to Influence Agriculture Operations Outlook
by Rajani Lohia
The U.S. agriculture exports are widely impacted by the tariff war with China, the largest importer of U.S. soybeans. Nevertheless, initial U.S.-China trade talks bring hopes for the industry.
Archer Daniels' Cost Savings & Project Readiness Bode Well
by Zacks Equity Research
Archer Daniels (ADM) gains from its strategic initiatives such as cost savings, management of business portfolio and Project Readiness.
Calyxt (CLXT) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Calyxt (CLXT) delivered earnings and revenue surprises of -4.00% and -99.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Can Clorox's Strategic Growth Efforts Offset Margin Issues?
by Zacks Equity Research
Clorox (CLX) witnesses strained margins due to higher costs. Nevertheless, its 2020 Strategy and Go Lean initiative to rebuild margins are encouraging.
Archer Daniels Rides on Solid Cost Saving & Readiness Efforts
by Zacks Equity Research
Archer Daniels (ADM) gains from its strategic efforts, including cost-savings plan, Project Readiness and management of business portfolio.
The Zacks Analyst Blog Highlights: Archer-Daniels, Monster Beverage, Blue Apron, Calyxt and Ollie's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Archer-Daniels, Monster Beverage, Blue Apron, Calyxt and Ollie's
5 Top Consumer Staples to Buy Stocks Amid a Volatile Market
by Nalak Das
The broad-based market decline can be attributed to lingering tariff related conflicts with China, plummeting crude oil prices, several geopolitical problems and yield curve inversion of sovereign bonds.
Agriculture-Operations Industry Rides Wave of Organic Foods
by Zacks Equity Research
Increasing shift to organic production techniques to satisfy changing consumer preference should bolster demand for agri-based products.
Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Calyxt (CLXT) delivered earnings and revenue surprises of 17.86% and -94.60%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Archer Daniels (ADM) Q3 Earnings Beat, Sales Miss Estimates
by Zacks Equity Research
Archer Daniels (ADM) posts mixed results for the third quarter of 2018.
Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Clorox's (CLX) Growth Strategies Offset Margin Woes?
by Zacks Equity Research
Clorox's (CLX) solid growth strategies, including 2020 Strategy, bode well. These initiatives are likely to offset margin pressures moving ahead.
Avon to Consolidate US Operations Into New York Facility
by Zacks Equity Research
Avon (AVP) is making efforts to simplify its U.S. business in a bid to fuel growth. However, this move will lead to head count reductions of roughly 100 employees.
Avon Stock Rallies on Takeover Talks With Brazil's Natura
by Zacks Equity Research
Avon (AVP) gains on rumors of a possible buyout by Natura & Co, the leading Brazilian cosmetics company.
4 Reasons Why You Should Invest in Archer Daniels Stock
by Zacks Equity Research
Archer Daniels' (ADM) progresses on its portfolio management initiatives, cost-savings plan and Readiness program bodes well.
Newell Feels the Pinch of Soft Q2: Is it Time to Offload?
by Zacks Equity Research
Newell (NWL) disappoints investors with its unimpressive top-line performance. Also, it is witnessing margin constraints for a while now due to cost inflation and adverse product mix.
Archer Daniels (ADM) Up 26% YTD: Will the Momentum Continue?
by Zacks Equity Research
Archer Daniels (ADM) looks promising backed by cost-savings efforts and management of its business portfolio. The company has an impressive earnings surprise trend as well.
Newell to Divest Goody Products, Transformation Plan Underway
by Zacks Equity Research
Newell Brands (NWL) announces an agreement with ACON Investments, L.L.C., to divest Goody Products, Inc. This indicates the company is on track with its Transformation Plan.
Newell (NWL) Beats on Q2 Earnings, Lags Sales, Trims '18 View
by Zacks Equity Research
Newell (NWL) posts mixed second-quarter 2018 results. Further, the company updates its Transformation Plan and guidance for the full year.
Clorox's (CLX) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Clorox (CLX) posts better-than-expected earnings in fourth-quarter fiscal 2018 owing to higher revenues, lower tax rate and advertising costs as well as gains from cost savings.